MODEL_Consortium @ModelConsortium X Profile

MODEL_Consortium

@ModelConsortium

Followers

77

Following

92

Media

1

Statuses

67

Muti-Organ Dysfunction and Evaluation for Liver transplantation Consortium. Honoring Vinay Sundaram's vision to assess natural history postOLT outcomes in ACLF

Joined November 2022

Don't wanna be here? Send us removal request.

Shifa Umar, MD

@shifaumarMD

6 months

Outstanding course by our team @bcm_gihep—For all third space endoscopy enthusiasts! Stay tuned! ⌚️🗓️ @EndoscopyOthman @KeihanianTara @GiJawaid

Endoscopy On Air

@EndoscopyOA

6 months

⚡ ESD in 2025: What’s Changed? What’s Coming? What You Need to Know. During the 5th Annual Transluminal & Third Space Endoscopy Workshop we will explore: - Esophageal ESD: Scope control, resection margins, newer knives (8:15–8:30 AM) - Gastric ESD: Lesion selection strategies,

0

6

26

AIG Hospitals

@AIGHospitals

7 months

It's back! The most awaited scientific conference covering the entire spectrum of Liver diseases, featuring the best of international faculty and an exhaustive scientific program, the AIG Liver Conclave 2025 is coming up on 26th & 27th September in Hyderabad. Save the date and

1

10

38

Hashem el- Serag

@SeragHashem

7 months

Our recent work using UK Biobank Shared genetic architecture of non-viral cirrhosis predisposition and BMI, ALT, and diabetes. Shared genetic architecture of non-viral cirrhosis with several pleiotropic traits: A nested case-control study in …

pubmed.ncbi.nlm.nih.gov

This study provides a comprehensive assessment of the shared genetic architecture of non-viral cirrhosis predisposition and numerous polygenic and pleiotropic traits, most notably BMI, alanine...

1

5

12

Mariam Naveed, MD

@MN_GIMD

7 months

We didn’t mean to flood @DDWMeeting but when your faculty–fellow team is this unstoppable, the research just keeps coming. If you see smoke in the hallways, it’s from the 🔥 they’re bringing. Catch their work—and maybe catch us sprinting between sessions like it’s the GI

2

19

100

Shifa Umar, MD

@shifaumarMD

8 months

2️⃣4️⃣Annual Baylor College of Medicine GI & LIVER COURSE 🗓️ April 12-13th Learn about cutting-edge approaches in hepatology, IBD, AI , IGI & much more 🚀 Link to register ✅ https://t.co/ZQD83d2FJ0

0

13

26

Eur. Fdn. for the Study of Chronic Liver Failure

@ef_clif

8 months

For the past decade, we’ve worked with @idibaps & @hospitalclinic to turn discoveries into clinical impact. Now renewed for 3 more years, this partnership will keep driving translational research in #chronicliverdisease. Learn more:

efclif.com

The first Grifols Chair Symposium takes on a special significance as we celebrate a decade of groundbreaking advancements in liver disease translational research. The event, taking place on 26 March...

0

4

9

Mimi Tan

@MimiTanMD

8 months

Just discussed this important paper by @ruben_hernaez @GCholankeril @KanwalFasiha @avegailf @HowardTLeeMD @KavishPatidar11 today at @bcm_gihep grand rounds!

HEPATOLOGY Journal

@HEP_Journal

8 months

Original Article Corticosteroids in severe alcohol-associated hepatitis? Not so fast: A systematic review of randomized controlled trials Shi, Pungwe et al. #LiverX https://t.co/uVw97oSsZn

1

4

18

Vanderbilt University Medical Center

@VUMCDiscoveries

9 months

Richard Peek, MD, director of the Division of Gastroenterology, Hepatology and Nutrition, has been elected vice president of the @AmerGastroAssn, the specialty’s primary and most influential international organization. Congratulations, Dr. Peek! https://t.co/dN4sItueMC

news.vumc.org

Richard Peek has been elected vice president of the American Gastroenterological Association, the specialty’s primary international organization.

4

9

34

Kavish Patidar

@KavishPatidar11

9 months

What is the relationship btwn terlipressin & MAP From the genius of @JoeCullaro https://t.co/wjtcnR9oWR 🔥post-hoc analysis, patient-level data from REVERSE and CONFIRM. 🔥In a time dependent model, 5 mmHg ⬆️ in MAP was associated with 1.17x the hazard of HRS-AKI reversal.

journals.lww.com

trials REVERSE and CONFIRM. Approach and Results: In this post hoc analysis we employed a linear mixed-effects model to assess terlipressin’s impact on MAP, exploring the relationship between MAP,...

2

5

18

From the Labs at Baylor College of Medicine

@BCMFromtheLabs

10 months

.@ruben_hernaez @KanwalFasiha @avegailf @rabataller @juanpabloarab @GCholankeril @KavishPatidar11 @HowardTLeeMD @Dr_Vijay_Shah @magicbaby6 @AsraniSumeet have new recommendations for #corticosteroid use in #alcoholAssociatedHepatitis @bcmhouston #review

journals.lww.com

events. We aim to systematically review these variables and provide evidence-based recommendations for the inpatient and outpatient management of severe AH. Approach and Results: We performed a...

0

13

20

Eur. Fdn. for the Study of Chronic Liver Failure

@ef_clif

1 year

At the General Assembly of the @EASLnews-#CLIFConsortium, we reviewed achievements of the previous year and progress of ongoing studies. The meeting also served as a platform for presenting upcoming clinical studies, furthering our commitment to advancing liver disease research.

1

10

Howard T. Lee MD FAST

@HowardTLeeMD

1 year

Excited to join the Medical Director Forum at @ATCMeeting this year on behalf of our medical director Dr. Rise Stribling @bcm_gihep @StLukesHealthTX 💵Compensation models 🏥build and grow your LDLT program 👨‍⚕️Liver ICU model @AST_LICOP @AST_info #LiverTwitter

0

6

21

Lizzie Aby, MD

@LizzieAbyMD

2 years

Excited for the upcoming debate at #DDW2024 Should patients w/alcohol related liver disease & a hx of decompensation be considered for early liver #transplantation? Featuring Jay Luther of @MGH_GI & Brian Lee of @USC_KeckGILiver! 🗓️Sat May 18 ⏰10-11A ET 📍202A #livertwitter

2

6

53

Kavish Patidar

@KavishPatidar11

2 years

Need a contemporary review on HRS-AKI and the role of terlipressin? See our article in @HEP_Journal https://t.co/ZJKqjGTMl3 @JoeCullaro @AASLDtweets Ann Ma, Andrew Allegretti. #livertwitter

journals.lww.com

fusion. While liver transplantation is the only definitive “cure” for HRS, medical management with vasoconstrictors and i.v. albumin is a cornerstone of supportive care. Terlipressin, a V1a receptor...

0

6

26

Eur. Fdn. for the Study of Chronic Liver Failure

@ef_clif

2 years

Great discussion with the #CHANCE Steering Committee and Management Team this p.m. to review preliminary data as we are approaching our 1000th patient milestone. Thank you everyone for your enthusiasm and commitment! #ACLF #livertransplantation @EASLnews @ESOTtransplant @_ILTS_

1

5

13

Ruben Hernaez

@ruben_hernaez

2 years

@JHepatology @EASLnews @EASLedu @ProfPaoloAngeli @JVLazarus @AleksanderKrag Still honoring @VinaySundaramMD from the @ModelConsortium @RajivJalan1 @dean_karvellas

0

5

15

BCM Gastroenterology

@bcm_gihep

2 years

@ruben_hernaez @dean_karvellas #thierry_artzner @RajivJalan1 @ModelConsortium provide a tool to prognosticate mortality after liver transplantation in #aclf #LiverTwitter Congrats 👏 @IQuEStHouston @BCMDeptMedicine @JHepatology https://t.co/eDnHM6XXes

0

6

11

Eur. Fdn. for the Study of Chronic Liver Failure

@ef_clif

2 years

We are delighted to host a networking session at #EASLCongress 2023. Stop by the #Cirrhosis & Complications Track Hub on 21 June 16:00 - 17:00 to explore ways to collaborate with us!

EASLnews

@EASLnews

2 years

Our partners @ef_clif are hosting a networking session at #EASLCongress! This is your opportunity to discover this great team and learn more about chronic liver failure. Join us! 📅 Wednesday 21 June, 16:00 – 17:00 📌 Cirrhosis & Complications Track Hub All information on

0

1

6

Prof Rajiv Jalan

@RajivJalan1

2 years

https://t.co/KQorIDMRcj @JHepatology @ef_clif @UK_CLIF @ruben_hernaez @_ILTS_ @VinaySundaramMD ✅SALT-M score provides online calculator to estimate risk of death following liver transplantation for ACLF patients🔆🔆🔆The score is named after the inspirational late Vinay Sundaram

3

25

51